OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefanía Moreno, Clara Andradas, Mireia Medrano, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 32, pp. 21960-21972
Open Access | Times Cited: 105
Estefanía Moreno, Clara Andradas, Mireia Medrano, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 32, pp. 21960-21972
Open Access | Times Cited: 105
Showing 1-25 of 105 citing articles:
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2266
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2266
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino, Tiziana Bisogno, Vincenzo Di Marzo
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 9-29
Closed Access | Times Cited: 776
Luigia Cristino, Tiziana Bisogno, Vincenzo Di Marzo
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 9-29
Closed Access | Times Cited: 776
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
G Protein–Coupled Receptor Heteromers
Ivone Gomes, Mohammed Akli Ayoub, Wakako Fujita, et al.
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 403-425
Open Access | Times Cited: 247
Ivone Gomes, Mohammed Akli Ayoub, Wakako Fujita, et al.
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 403-425
Open Access | Times Cited: 247
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22
A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer
Sudharshan Reddy Dachani, Mohammed Kaleem, Md Ali Mujtaba, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10030-10048
Open Access | Times Cited: 15
Sudharshan Reddy Dachani, Mohammed Kaleem, Md Ali Mujtaba, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10030-10048
Open Access | Times Cited: 15
The use of cannabinoids as anticancer agents
Guillermo Velasco, Sonia Hernández‐Tiedra, David Dávila, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 259-266
Open Access | Times Cited: 155
Guillermo Velasco, Sonia Hernández‐Tiedra, David Dávila, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 259-266
Open Access | Times Cited: 155
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152
Anti‐tumour actions of cannabinoids
Burkhard Hinz, Robert Ramer
British Journal of Pharmacology (2018) Vol. 176, Iss. 10, pp. 1384-1394
Open Access | Times Cited: 129
Burkhard Hinz, Robert Ramer
British Journal of Pharmacology (2018) Vol. 176, Iss. 10, pp. 1384-1394
Open Access | Times Cited: 129
The Endocannabinoid System: A Target for Cancer Treatment
Chiara Laezza, Cristina Pagano, Giovanna Navarra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 747-747
Open Access | Times Cited: 122
Chiara Laezza, Cristina Pagano, Giovanna Navarra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 747-747
Open Access | Times Cited: 122
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
New Insights in Cannabinoid Receptor Structure and Signaling
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Daniel A. Ladin, Eman Soliman, LaToya M. Griffin, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 99
Daniel A. Ladin, Eman Soliman, LaToya M. Griffin, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 99
GPR55 – a putative “type 3” cannabinoid receptor in inflammation
Hye-Won Yang, Juan Zhou, Christine Lehmann
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 297-302
Open Access | Times Cited: 97
Hye-Won Yang, Juan Zhou, Christine Lehmann
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 297-302
Open Access | Times Cited: 97
Anandamide, Acting viaCB2Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
Natalia Małek, Katarzyna Popiołek-Barczyk, Joanna Mika, et al.
Neural Plasticity (2015) Vol. 2015, pp. 1-10
Open Access | Times Cited: 96
Natalia Małek, Katarzyna Popiołek-Barczyk, Joanna Mika, et al.
Neural Plasticity (2015) Vol. 2015, pp. 1-10
Open Access | Times Cited: 96
Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands
Mireille Alhouayek, Julien Masquelier, Giulio G. Muccioli
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 6, pp. 586-604
Closed Access | Times Cited: 89
Mireille Alhouayek, Julien Masquelier, Giulio G. Muccioli
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 6, pp. 586-604
Closed Access | Times Cited: 89
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
Cristina Anna Gallelli, Silvio Calcagnini, Adele Romano, et al.
Antioxidants (2018) Vol. 7, Iss. 7, pp. 93-93
Open Access | Times Cited: 89
Cristina Anna Gallelli, Silvio Calcagnini, Adele Romano, et al.
Antioxidants (2018) Vol. 7, Iss. 7, pp. 93-93
Open Access | Times Cited: 89
Cannabidiol (CBD) in Cancer Management
Kylie O’Brien
Cancers (2022) Vol. 14, Iss. 4, pp. 885-885
Open Access | Times Cited: 49
Kylie O’Brien
Cancers (2022) Vol. 14, Iss. 4, pp. 885-885
Open Access | Times Cited: 49
The GPR 55 antagonist CID 16020046 protects against intestinal inflammation
Angela Stančić, Katharina Jandl, Carina Hasenöhrl, et al.
Neurogastroenterology & Motility (2015) Vol. 27, Iss. 10, pp. 1432-1445
Open Access | Times Cited: 87
Angela Stančić, Katharina Jandl, Carina Hasenöhrl, et al.
Neurogastroenterology & Motility (2015) Vol. 27, Iss. 10, pp. 1432-1445
Open Access | Times Cited: 87
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
Farideh Javid, Roger M. Phillips, S. Afshinjavid, et al.
European Journal of Pharmacology (2016) Vol. 775, pp. 1-14
Open Access | Times Cited: 74
Farideh Javid, Roger M. Phillips, S. Afshinjavid, et al.
European Journal of Pharmacology (2016) Vol. 775, pp. 1-14
Open Access | Times Cited: 74
Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors
Andrew J. Irving, Ghayth Abdulrazzaq, Sue Chan, et al.
Advances in pharmacology (2017), pp. 223-247
Closed Access | Times Cited: 68
Andrew J. Irving, Ghayth Abdulrazzaq, Sue Chan, et al.
Advances in pharmacology (2017), pp. 223-247
Closed Access | Times Cited: 68
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
Robert Ramer, Rico Schwarz, Burkhard Hinz
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 66
Robert Ramer, Rico Schwarz, Burkhard Hinz
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 66
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Paula Morales, Laura Hernández‐Folgado, Pilar Goya, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 7, pp. 843-856
Closed Access | Times Cited: 65
Paula Morales, Laura Hernández‐Folgado, Pilar Goya, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 7, pp. 843-856
Closed Access | Times Cited: 65
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
Irene Reyes‐Resina, Gemma Navarro, David Aguinaga, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 169-179
Open Access | Times Cited: 65
Irene Reyes‐Resina, Gemma Navarro, David Aguinaga, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 169-179
Open Access | Times Cited: 65
